Shaw and Partners successfully raised $30.7 million for Revasum, which today listed on the ASX under code ASX:RVS.

The deal was strongly supported by both institutional and retail investors.

Revasum is a Californian based firm that manufactures equipment to make microchips used in mobile phones, cars, and internet-connected devices. Its technology enables manufacturers of semiconductor substrates and devices to reliably produce at higher yields and lower costs to their competitors.

Strong quarterly results from international semiconductor (SC) companies and evidence of ongoing capex growth (memory and other SC’s) provide a solid backdrop for investors in the increasingly broader ASX SC sector.

Since pricing the deal / placing RVS, the semiconductor industry has rallied 13.5%.

Revasum has recently made an announcement highlighting the following:

• 100% of forecast system revenue for the 6 months to 31 December 2018 has either been shipped, or is under purchase orders (with deposits paid) and due to be shipped, prior to 31 December 2018.
• 63% of 1H 2019 forecast system revenue now under confirmed purchase order, versus ~50% at Prospectus date
• Revasum has recently been selected as the strategic partner for Silicon Carbide production by major semiconductor device manufacturer – a key endorsement of Revasum’s technical expertise

As Corporate Adviser to Revasum, Shaw and Partners looks forward to working with Revasum in the future.